Gender-affirming care, on your terms.
Informed-consent GAHT in Bellingham — gender-affirming hormone therapy delivered inside a full concierge primary care relationship, not a single-purpose hormone visit. We are not a gender clinic. We are a primary care practice that treats trans and non-binary patients as patients first, with GAHT as one of the things we prescribe and monitor.
Who this
care is for.
- Adults seeking gender-affirming hormone therapy in Bellingham
- Existing GAHT patients seeking continuity of care after moving or losing a provider
- Patients who want medical supervision under an informed-consent model
- Patients seeking shorter waitlists than the large regional clinics
- Patients looking for integration with broader primary care
- Patients comfortable with a paid-cash, no-insurance billing model
- Adults exploring whether GAHT is right for them
What this practice is, and isn't.
We provide gender-affirming hormone therapy under an informed-consent model — no letter from a therapist required, no extended psychological gatekeeping, no requirement to prove anything to us before we start. We do require what we'd require for any medication that meaningfully affects the body: a real conversation about goals, a baseline workup, and ongoing follow-up.
- ✓Informed-consent model — adults decide for themselves with appropriate medical information.
- ✓No letters required to begin or continue GAHT.
- ✓Same provider every visit — continuity, not rotation.
- ✓We don't compete with subsidized or sliding-scale clinics — if cost is the primary barrier, we'll point you to Spectrum Reproductive Health and other Bellingham-area resources.
Pricing — for everyone.
Gender-affirming care at Mt. Baker Medical is available to anyone — no membership required. Members include the consult, save 15% on medications, and access full primary care.
| Retail | Member | |
|---|---|---|
| Feminizing GAHTMonthly · estradiol + spironolactone (or alternatives) · compounded · clinical management included | $229 / mo | $179 / mo |
| Masculinizing GAHTMonthly · testosterone (IM or topical) · clinical management included | $249 / mo | $199 / mo |
| Specialty protocolsNon-binary, micro-dosing, atypical regimens, or complex cases · individualized | $279 / mo | $219 / mo |
| One-time GAHT consultRequired at intake for new patients · 60 minutes · included for members | $295 | Included |
How we approach it.
Same physician across every visit. Real labs, real follow-up, real continuity. Informed-consent model means we don't gatekeep — but we do practice real medicine.
60-minute intake.
If you’re searching for gender-affirming care in Bellingham and trying to figure out whether informed-consent GAHT is available without a letter from a therapist or a six-month waiting period: yes, here it is. Your story, your goals, your timeline, your medical history. We talk through what’s realistic, what’s expected, and what informed consent actually covers.
Baseline labs.
Comprehensive metabolic panel, lipids, hormonal panel (estradiol, testosterone, SHBG), CBC, thyroid. Establishes the reference point for everything that follows.
Start, titrated.
Begin at a starting dose appropriate to your goals. Most patients reach target levels over 3–6 months of titration, with follow-up labs every 6–12 weeks at first.
Ongoing care.
Once stable, follow-up labs every 6–12 months. Same provider, same continuity, lifelong if that's the choice.
What we offer.
Three protocol categories. All under informed-consent model, all medically supervised, all individualized to your specific picture rather than a stock regimen.
Feminizing GAHT.
Estradiol (oral, sublingual, injectable, or patch) with anti-androgen support (typically spironolactone or alternatives based on tolerance). Doses titrated based on lab response and your subjective experience. Most patients reach target estradiol levels in 3–6 months.
Masculinizing GAHT.
Testosterone via IM, subcutaneous, or topical route. Dose chosen for your specific goals and tolerated by your specific hematocrit response. Standard induction reaches target levels in 2–4 months.
Specialty protocols.
Non-binary regimens, micro-dosing, atypical timelines, complex medical histories. We work through what you're aiming for and build the protocol that fits, rather than forcing a stock regimen onto a non-stock situation.
Common questions.
The five questions we get most. Schema-eligible for AI Overview citation.
What is informed-consent gender-affirming care?
Informed-consent gender-affirming care means adults can begin gender-affirming hormone therapy after a thorough conversation with the prescribing physician about risks, benefits, expected effects, timelines, and ongoing monitoring — without requiring a letter from a therapist or other psychological gatekeeping. The model recognizes that adults are capable of making informed medical decisions about their own bodies, similarly to how informed consent works for other medications that meaningfully affect the body.
Do I need a therapist's letter to start GAHT here?
No. We provide gender-affirming care under an informed-consent model, which means a therapist's letter is not required to begin or continue hormone therapy. We do require an initial 60-minute consult with the prescribing physician to discuss goals, expectations, baseline labs, and ongoing monitoring — but that's medical care, not gatekeeping.
How long does it take to start GAHT?
From first call to first prescription is typically 2–4 weeks, depending on lab scheduling. The sequence is: initial consult booking, 60-minute intake visit, baseline lab draw, lab results review (1–2 weeks), then prescription initiation. Patients transferring from another provider with current labs and existing protocols can often start sooner — bring your records.
What's the difference between feminizing and masculinizing GAHT?
Feminizing GAHT uses estradiol (with anti-androgen support like spironolactone) to develop more typically feminine secondary sex characteristics — breast development, body fat redistribution, softer skin, reduced muscle mass. Masculinizing GAHT uses testosterone to develop more typically masculine characteristics — voice deepening, facial and body hair, body fat redistribution, increased muscle mass. Both protocols are individualized; not everyone is pursuing all changes.
Is gender-affirming care safe?
Yes — gender-affirming hormone therapy has a substantial body of clinical evidence supporting its safety when properly supervised. Risks include cardiovascular effects (managed with lipid and lab monitoring), elevated hematocrit (for testosterone), and rare clotting events (for higher-dose estradiol). These are tracked through scheduled lab work and addressed if and when they arise. The risks of GAHT under medical supervision are well-characterized and well-managed.
Start with a free conversation.
15 minutes by phone, no charge. We talk through what you're looking for and what care here would look like. If we're not the right fit, we'll say so and point you toward who is.
Or call(360) 498-7529